biopharmaceutical company is looking for volunteers in the next phase of trials for a potential new treatment for Alzheimer’s disease. , has been developing LIFT-AD, which is aimed at people living with mild-to-moderate Alzheimer’s.
"These injections, every day patients take it, and the hope is that it helps the nerve cells to connect to each other better," said Doctor Arif Khan is helping to run the LIFT-AD trial at the Northwest Clinical Research Center. Robert Guant and his wife Sharon are among them. The former FEMA and King County worker was diagnosed with Alzheimer’s disease three years ago. He’s already participated in two clinical trials for other drugs and may enroll in the LIFT-AD study next.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: